Leuk Res

Hepatitis B vaccination in acute lymphoblastic leukemia.

Year 1998
Goyal S. Pai SK. Kelkar R. Advani SH.
Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, India.
Active immunization against hepatitis B virus infection was carried out in 162 patients with acute lymphoblastic leukemia attending the Outpatient Department at Tata Memorial Hospital. Recombinant DNA vaccine was given in three doses at 0, 1 and 2 months followed by a booster 1 year after the first dose. Antibodies to hepatitis B surface antigen could be detected in 19.7% of patients following vaccination. Of these only 10.5% had titers in the protective range. Immunosuppression induced by both disease and treatment appears to diminish responsiveness to vaccination. Passive active prophylaxis with both vaccine and immunoglobulin may be a more effective alternative in these patients.